NIFTY  8,896.70  -0.48%
  SENSEX  28,812.90  -0.28%
 CURRENCY  Rs  66.83/$ 70.65/€, 83.79/£
  GOLD  29,717.00  0.32%
  SILVER  43,440.00  0.20%
  DAX  11,822.70  0.16%
  FTSE  7,253.00  0.13%
  CAC  4,845.18  -0.00%
  HANG SENG  23,925.10  -0.17%
  NIKKEI  19,107.50  -0.91%
  Shanghai Composite  3,228.66  -0.42%
  DOW JONES  20,837.40  0.07%
  NASDAQ  5,861.90  0.28%
  S&P 500  2,369.75  0.10%
SANOFI INDIA Q4 - Net Sales At Rs 552 Cr Vs Rs 522 Cr YoY SANOFI INDIA Q4 - Net Profit At Rs 50.5 Cr Vs Rs 120 Cr YoY

Need Protection For Drug Manufacturers: IPA

Video:

Play this video

August 6: Stating that the pharma industry is looking for an amicable resolution to the drug pricing policy issue, D.G. Shah, Secretary General of the Indian Pharmaceutical Alliance, says that in case of a logjam they may seek court intervention. “The government just gave us 45 days to bring back and re-stamp medicines worth Rs. 2,000 crore and no clarity was provided on excise duty refund,” he adds.